Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (25 quarters reported)
$377M in Q4 2019 → $875M now. Hover for any quarter.
As reported for the quarter ended December 31, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| CR Charles Riv Labs Intl Inc | 8.7% | Added 42% | 379,728 | $75.7M |
| Intuitive Surgical Inc | 6.1% | New | 94,459 | $53.5M |
| Repligen Corp | 6.0% | Added 19% | 320,474 | $52.5M |
| Jazz Pharmaceuticals PLC | 5.7% | Added 95% | 292,170 | $49.7M |
| Veracyte Inc | 4.7% | Added 102% | 980,391 | $41.3M |
| Boston Scientific Corp | 4.6% | New | 420,773 | $40.1M |
| Waters Corp | 4.6% | New | 105,167 | $39.9M |
| BS Brookdale Sr Living Inc | 4.3% | Added 23% | 3,491,663 | $37.7M |
| EL Eli Lilly & Co | 4.3% | Trimmed 29% | 35,045 | $37.7M |
| Bruker Corp | 4.3% | New | 794,380 | $37.4M |
| Vertex Pharmaceuticals Inc | 4.0% | New | 76,910 | $34.9M |
| Cvs Health Corp | 3.9% | Trimmed 46% | 432,457 | $34.3M |
| FH Fortrea Hldgs Inc | 3.9% | New | 1,986,333 | $34.3M |
| MM Merit Med Sys Inc | 3.9% | New | 385,660 | $34M |
| BH Brightspring Health Svcs Inc | 3.8% | Trimmed 28% | 897,427 | $33.6M |
| Doximity Inc | 3.5% | Added 227% | 686,568 | $30.4M |
| Bio-techne Corp | 3.1% | New | 467,409 | $27.5M |
| AH Alphatec Hldgs Inc | 3.1% | New | 1,285,685 | $27.1M |
| Adapthealth Corp | 3.0% | Added 36% | 2,609,003 | $26M |
| Envista Holdings Corporation | 2.9% | New | 1,186,704 | $25.8M |
| Unitedhealth Group Inc | 2.6% | New | 70,126 | $23.1M |
| AL Abbott Labs | 2.5% | New | 175,333 | $22M |
| Ideaya Biosciences Inc | 1.8% | Added 73% | 467,484 | $16.2M |
| Biohaven Ltd | 1.2% | New | 958,336 | $10.8M |
| Xenon Pharmaceuticals Inc | 1.2% | New | 233,688 | $10.5M |
| Dianthus Therapeutics Inc | 1.1% | New | 230,730 | $9.51M |
| Mineralys Therapeutics Inc | 1.1% | New | 257,085 | $9.33M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Dexcom Inc | Exited | −850,000 | −$57.2M | — |
| Intuitive Surgical Inc | New | +94,459 | +$53.5M | 6.1% |
| Abbvie Inc | Exited | −200,326 | −$46.4M | — |
| Medtronic PLC | Exited | −453,347 | −$43.2M | — |
| Boston Scientific Corp | New | +420,773 | +$40.1M | 4.6% |
| Waters Corp | New | +105,167 | +$39.9M | 4.6% |
| Bruker Corp | New | +794,380 | +$37.4M | 4.3% |
| Vertex Pharmaceuticals Inc | New | +76,910 | +$34.9M | 4.0% |
| FH Fortrea Hldgs Inc | New | +1,986,333 | +$34.3M | 3.9% |
| MM Merit Med Sys Inc | New | +385,660 | +$34M | 3.9% |
Showing the 10 largest of 41 changes.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Dexcom Inc | New | +850,000 | +$57.2M | 8.1% |
| EL Eli Lilly & Co | New | +49,555 | +$37.8M | 5.4% |
| MM Merit Med Sys Inc | Exited | −392,783 | −$36.7M | — |
| Icon PLC | Exited | −250,000 | −$36.4M | — |
| Repligen Corp | New | +270,000 | +$36.1M | 5.1% |
| Intuitive Surgical Inc | Exited | −60,000 | −$32.6M | — |
| Hca Healthcare Inc | Exited | −80,000 | −$30.6M | — |
| Madrigal Pharmaceuticals Inc | New | +58,378 | +$26.8M | 3.8% |
| Insulet Corp | Exited | −68,041 | −$21.4M | — |
| Jazz Pharmaceuticals PLC | New | +150,000 | +$19.8M | 2.8% |
Showing the 10 largest of 37 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Cvs Health Corp | New | +750,000 | +$51.7M | 7.9% |
| Davita Inc | Exited | −319,566 | −$48.9M | — |
| CR Charles Riv Labs Intl Inc | New | +320,000 | +$48.6M | 7.5% |
| Icon PLC | New | +250,000 | +$36.4M | 5.6% |
| Medtronic PLC | New | +400,000 | +$34.9M | 5.4% |
| TP Teva Pharmaceutical Inds Ltd | Exited | −2,217,730 | −$34.1M | — |
| Boston Scientific Corp | Exited | −332,167 | −$33.5M | — |
| Cardinal Health Inc | Trimmed | −194,743 | −$32.7M | 2.7% |
| GM Globus Med Inc | Exited | −431,221 | −$31.6M | — |
| Hca Healthcare Inc | New | +80,000 | +$30.6M | 4.7% |
Showing the 10 largest of 37 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Unitedhealth Group Inc | Exited | −120,700 | −$61.1M | — |
| Unitedhealth Group Inc | Exited | −100,000 | −$50.6M | — |
| Agilent Technologies Inc | Trimmed | −387,888 | −$45.4M | 3.8% |
| Abbvie Inc | Trimmed | −181,193 | −$38M | 6.4% |
| Exact Sciences Corp | Exited | −600,000 | −$33.7M | — |
| Healthequity Inc | Exited | −335,614 | −$32.2M | — |
| GM Globus Med Inc | Trimmed | −412,792 | −$30.2M | 5.0% |
| MH Medpace Hldgs Inc | Exited | −90,000 | −$29.9M | — |
| Tenet Healthcare Corp | New | +209,454 | +$28.2M | 4.4% |
| Astrazeneca PLC | New | +376,330 | +$27.7M | 4.4% |
Showing the 10 largest of 35 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Agilent Technologies Inc | New | +596,326 | +$80.1M | 8.8% |
| GM Globus Med Inc | New | +844,013 | +$69.8M | 7.7% |
| Abbvie Inc | New | +374,012 | +$66.5M | 7.3% |
| Elanco Animal Health Inc | Exited | −4,263,343 | −$62.6M | — |
| Unitedhealth Group Inc | New | +120,700 | +$61.1M | 6.7% |
| Illumina Inc | Exited | −440,000 | −$57.4M | — |
| Tenet Healthcare Corp | Exited | −308,940 | −$51.3M | — |
| AH Acadia Healthcare Company In | Exited | −802,151 | −$50.9M | — |
| Unitedhealth Group Inc | New | +100,000 | +$50.6M | 5.6% |
| Boston Scientific Corp | New | +495,009 | +$44.2M | 4.9% |
Showing the 10 largest of 39 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | Exited | −727,180 | −$67.2M | — |
| Dexcom Inc | Exited | −582,199 | −$66M | — |
| MH Medpace Hldgs Inc | New | +192,842 | +$64.4M | 8.9% |
| Illumina Inc | New | +440,000 | +$57.4M | 7.9% |
| Mckesson Corp | Exited | −92,125 | −$53.8M | — |
| Tenet Healthcare Corp | New | +308,940 | +$51.3M | 7.1% |
| Abbvie Inc | Exited | −284,657 | −$48.8M | — |
| Biomarin Pharmaceutical Inc | Exited | −555,140 | −$45.7M | — |
| WP West Pharmaceutical Svsc Inc | Exited | −132,908 | −$43.8M | — |
| Envista Holdings Corporation | New | +2,189,369 | +$43.3M | 6.0% |
Showing the 10 largest of 39 changes.
quarter ended June 30, 2024 · filed August 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | New | +727,180 | +$67.2M | 6.8% |
| Insulet Corp | New | +264,041 | +$53.3M | 5.4% |
| Icon PLC | Exited | −150,853 | −$50.7M | — |
| Exact Sciences Corp | Exited | −700,000 | −$48.3M | — |
| Danaher Corporation | New | +187,011 | +$46.7M | 4.7% |
| Align Technology Inc | Exited | −141,958 | −$46.6M | — |
| Biomarin Pharmaceutical Inc | New | +555,140 | +$45.7M | 4.6% |
| Illumina Inc | Exited | −330,758 | −$45.4M | — |
| Bruker Corp | Exited | −466,521 | −$43.8M | — |
| IM Inspire Med Sys Inc | New | +281,992 | +$37.7M | 3.8% |
Showing the 10 largest of 39 changes.
quarter ended March 31, 2024 · filed May 15, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| UH Universal Hlth Svcs Inc | Exited | −321,886 | −$49.1M | — |
| Exact Sciences Corp | New | +700,000 | +$48.3M | 5.0% |
| WP West Pharmaceutical Svsc Inc | New | +119,736 | +$47.4M | 4.9% |
| Align Technology Inc | New | +141,958 | +$46.6M | 4.8% |
| IL Idexx Labs Inc | Exited | −76,025 | −$42.2M | — |
| Surgery Partners Inc | Exited | −1,044,530 | −$33.4M | — |
| Apellis Pharmaceuticals Inc | New | +550,000 | +$32.3M | 3.3% |
| FH Fortrea Hldgs Inc | New | +791,233 | +$31.8M | 3.3% |
| IM Inspire Med Sys Inc | Exited | −150,000 | −$30.5M | — |
| Neurocrine Biosciences Inc | New | +220,000 | +$30.3M | 3.1% |
Showing the 10 largest of 40 changes.
Loading...
